Greenwich LifeSciences, Inc.

NASDAQ:GLSI

Biotechnology

Healthcare
$20.58 -3.08%

-$0.74 today

Market cap
$302.08M
Beta
1.38
P/E (TTM)
-15.6
EPS (TTM)
-$1.49
52W Low $7.78High $34.10

Volume 0.71M

Average 0.14M

GLSI Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Greenwich LifeSciences, Inc.NASDAQ: GLSI

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares growth accelerates

Q1 FY2026 weighted avg shares of 14.57M shares rose 10.6% year over year, ahead of the +5.4% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 6.8% from the prior quarter. Over 3 fiscal years it compounded at +1.6% a year.

Context

  • Weighted avg shares increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +10.6% holds above the trailing-twelve-month pace of +5.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
14.57M+6.8% QoQ
Last fiscal yearDec 2025
13.53M+4.0% YoY
LTMMar 2026
13.8M+5.4% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+10.6%——
1 year+4.0%——
3-year CAGR+1.6%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
13.53M USD
Year-over-year change
+4.0%
4-year CAGR
+1.1%

Weighted Avg Shares vs competitors

How GLSI compares with its peers on the latest reported figures

  • GLSI's LTM Mar 2026 weighted avg shares of 13.8M shares is the 8th highest of the 9 companies compared; the peer median is 53.88M shares.
  • Its year-over-year change of +5.4% is the 8th highest of 9, against a peer median of +59.1%.
  • Over three fiscal years its annual growth of +1.6% compares with a peer median of +34.6%.
GLSI Competitors Peer median
Weighted Avg Shares for GLSI and competitors
Company Period LTM YoY 3-year CAGR
IRDOpus Genetics, Inc.LTM Mar 2026406.29M +1283.9%+214.9%
ONCYOncolytics Biotech Inc.LTM Mar 2026100.12M +27.6%+18.2%
CGTXCognition Therapeutics, Inc.LTM Mar 202679.93M +69.4%+35.9%
SEERSeer, Inc.LTM Mar 202656.96M -7.5%-2.7%
HURATuHURA Biosciences, Inc.LTM Mar 202650.79M +127.0%+911.7%
IMMXImmix Biopharma, Inc.LTM Mar 202634.62M +19.9%+33.4%
AGENAgenus Inc.LTM Mar 202633.32M +48.8%+28.3%
GLSIGreenwich LifeSciences, Inc.LTM Mar 202613.8M +5.4%+1.6%
SRZNSurrozen, Inc.LTM Mar 20269.29M +179.8%+47.8%
Peer median (excluding GLSI) 53.88M+59.1%+34.6%

Competitors are the stored peer set for GLSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue3.61K3.61K3.61K3.61K1.78K
Gross Profit(3.61K)(3.61K)(3.61K)(3.61K)(1.78K)
Gross Margin—————
Research & Development3.56M6.48M7.7M15.48M17.22M
Selling, General & Admin1.04M1.56M1.63M2.15M2.23M
Operating Expenses4.59M8.04M9.32M17.63M19.45M
Depreciation & Amortization3.61K3.61K3.61K3.61K1.78K
EBITDA(4.57M)(7.82M)(8.89M)(17.41M)(19.36M)
EBITDA Margin—————
Operating Income(4.6M)(8.04M)(9.33M)(17.64M)(19.45M)
Operating Margin—————
Interest Income27.37K215.02K436.06K223.01K89.7K
Interest Expense00000
Other Income / Expenses27.37K215.02K436.06K223.01K89.7K
Income Before Tax(4.57M)(7.83M)(8.89M)(17.41M)(19.36M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(4.57M)(7.83M)(8.89M)(17.41M)(19.36M)
Net Margin—————
EPS (Basic)(0.35)(0.61)(0.69)(1.21)(1.43)
EPS (Diluted)(0.35)(0.61)(0.69)(1.21)(1.43)
Weighted Avg Shares12.94M12.91M12.85M13.01M13.53M
Weighted Avg Shares (Diluted)12.94M12.91M12.85M13.01M13.53M

Greenwich LifeSciences, Inc.

NASDAQ:GLSI

Intrinsic Alpha fair value

Locked

Current Price

$20.58

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.